Sign in
4

Changes in Ownership

PRECISION BIOSCIENCES INC Filed Acc 0001209191-23-046874

Chief Financial Officer acquired 90,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kelly John Alexander Chief Financial Officer 2023-08-18 Grant or award +90,000 $0.48 $43,200 383,340 D: show line 1 in the form
Loading xslF345X05/doc4.xml…